In the BioHarmony Drug Report Database
Emtricitabine
Emtriva (emtricitabine) is a small molecule pharmaceutical. Emtricitabine was first approved as Emtriva on 2003-07-02. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Emtriva’s patent is valid until 2021-03-09 (FDA).
Trade Name
|
Emtriva |
|---|---|
Common Name
|
emtricitabine |
ChEMBL ID
|
CHEMBL885 |
Indication
|
hiv infections |
Drug Class
|
Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |
Image (chem structure or protein)